Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Consulting Fee | $25,510 | 14 | 88.6% |
| Travel and Lodging | $1,630 | 5 | 5.7% |
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $1,000 | 1 | 3.5% |
| Food and Beverage | $542.30 | 7 | 1.9% |
| Grant | $95.00 | 1 | 0.3% |
| Education | $4.02 | 2 | 0.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Alnylam Pharmaceuticals Inc. | $13,960 | 7 | $0 (2023) |
| Novo Nordisk Inc | $5,808 | 9 | $0 (2024) |
| Retrophin, Inc. | $3,215 | 8 | $0 (2019) |
| Travere Therapeutics, Inc. | $3,003 | 3 | $0 (2024) |
| Novo Nordisk Health Care AG | $2,700 | 2 | $0 (2024) |
| BOSTON SCIENTIFIC CORPORATION | $95.00 | 1 | $0 (2018) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $3,819 | 4 | Novo Nordisk Health Care AG ($2,700) |
| 2023 | $4,789 | 5 | Alnylam Pharmaceuticals Inc. ($2,648) |
| 2022 | $4,712 | 7 | Novo Nordisk Inc ($3,552) |
| 2021 | $6,912 | 3 | Alnylam Pharmaceuticals Inc. ($6,912) |
| 2020 | $5,240 | 2 | Alnylam Pharmaceuticals Inc. ($3,240) |
| 2019 | $3,214 | 7 | Retrophin, Inc. ($3,214) |
| 2018 | $95.00 | 1 | BOSTON SCIENTIFIC CORPORATION ($95.00) |
| 2017 | $0.94 | 1 | Retrophin, Inc. ($0.94) |
All Payment Transactions
30 individual payment records from CMS Open Payments — Page 1 of 2
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 10/15/2024 | Travere Therapeutics, Inc. | — | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $1,000.00 | General |
| 07/09/2024 | Novo Nordisk Inc | — | Food and Beverage | In-kind items and services | $118.56 | General |
| 06/07/2024 | Novo Nordisk Health Care AG | — | Consulting Fee | Cash or cash equivalent | $1,800.00 | General |
| 06/07/2024 | Novo Nordisk Health Care AG | — | Consulting Fee | Cash or cash equivalent | $900.00 | General |
| 11/21/2023 | Travere Therapeutics, Inc. | — | Education | In-kind items and services | $3.08 | General |
| 11/05/2023 | Novo Nordisk Inc | — | Consulting Fee | Cash or cash equivalent | $1,800.00 | General |
| 11/05/2023 | Novo Nordisk Inc | — | Consulting Fee | Cash or cash equivalent | $337.50 | General |
| 08/03/2023 | Alnylam Pharmaceuticals Inc. | — | Consulting Fee | Cash or cash equivalent | $2,610.00 | General |
| 06/22/2023 | Alnylam Pharmaceuticals Inc. | — | Food and Beverage | In-kind items and services | $37.95 | General |
| 12/21/2022 | Alnylam Pharmaceuticals Inc. | — | Consulting Fee | Cash or cash equivalent | $1,160.00 | General |
| 11/06/2022 | Novo Nordisk Inc | — | Consulting Fee | Cash or cash equivalent | $1,800.00 | General |
| 11/06/2022 | Novo Nordisk Inc | — | Travel and Lodging | In-kind items and services | $539.33 | General |
| 11/06/2022 | Novo Nordisk Inc | — | Consulting Fee | Cash or cash equivalent | $450.00 | General |
| 11/06/2022 | Novo Nordisk Inc | — | Travel and Lodging | In-kind items and services | $349.81 | General |
| 11/06/2022 | Novo Nordisk Inc | — | Travel and Lodging | In-kind items and services | $337.02 | General |
| 11/06/2022 | Novo Nordisk Inc | — | Food and Beverage | In-kind items and services | $76.06 | General |
| 12/22/2021 | Alnylam Pharmaceuticals Inc. | OXLUMO (Drug) | Consulting Fee | Cash or cash equivalent | $1,620.00 | General |
| Category: Genetic Disease | ||||||
| 05/06/2021 | Alnylam Pharmaceuticals Inc. | OXLUMO (Drug) | Consulting Fee | Cash or cash equivalent | $1,890.00 | General |
| Category: Genetic Disease | ||||||
| 01/12/2021 | Alnylam Pharmaceuticals Inc. | — | Consulting Fee | Cash or cash equivalent | $3,402.00 | General |
| 12/22/2020 | Alnylam Pharmaceuticals Inc. | OXLUMO (Drug) | Consulting Fee | Cash or cash equivalent | $3,240.00 | General |
| Category: Genetic Disease | ||||||
| 09/10/2020 | Travere Therapeutics, Inc. | — | Consulting Fee | Cash or cash equivalent | $2,000.00 | General |
| 07/18/2019 | Retrophin, Inc. | (815) Thiola (Drug) | Consulting Fee | Cash or cash equivalent | $2,500.00 | General |
| Category: Kidney Stones | ||||||
| 07/18/2019 | Retrophin, Inc. | (815) Thiola (Drug) | Travel and Lodging | Cash or cash equivalent | $116.24 | General |
| Category: Kidney Stones | ||||||
| 07/04/2019 | Retrophin, Inc. | (815) Thiola (Drug) | Food and Beverage | In-kind items and services | $70.55 | General |
| Category: Kidney Stones | ||||||
| 06/29/2019 | Retrophin, Inc. | (815) Thiola (Drug) | Travel and Lodging | Cash or cash equivalent | $287.98 | General |
| Category: Kidney Stones | ||||||
About Dr. Michelle Baum, MD
Dr. Michelle Baum, MD is a Pediatric Nephrology healthcare provider based in Boston, Massachusetts. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 01/30/2006. The National Provider Identifier (NPI) number assigned to this provider is 1104897925.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Michelle Baum, MD has received a total of $28,781 in payments from pharmaceutical and medical device companies, with $3,819 received in 2024. These payments were reported across 30 transactions from 6 companies. The most common payment nature is "Consulting Fee" ($25,510).
Practice Information
- Specialty Pediatric Nephrology
- Other Specialties Pediatrics
- Location Boston, MA
- Active Since 01/30/2006
- Last Updated 04/28/2014
- Taxonomy Code 2080P0210X
- Entity Type Individual
- NPI Number 1104897925
Products in Payments
- OXLUMO (Drug) $6,750
- (815) Thiola (Drug) $3,215
- GENERAL KIDNEY STONE DISEASE (Device) $95.00
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Pediatric Nephrology Doctors in Boston
Avram Traum, M.d, M.D
Pediatric Nephrology — Payments: $21,960
Weizhen Tan, Md, MD
Pediatric Nephrology — Payments: $14,515
Dr. Isa Ashoor, M.d, M.D
Pediatric Nephrology — Payments: $203.52
Paul Fadakar, Md, MD
Pediatric Nephrology — Payments: $150.79
Elena Zion, M.d, M.D
Pediatric Nephrology — Payments: $118.56
Dr. Ghaleb Daouk, Md, MD
Pediatric Nephrology — Payments: $66.70